Evidence-based clinical review Intratumoral Immunotherapy and In-Situ Vaccination: Local Shots, Systemic Responses? What clinicians should know about tumor-directed immune therapy, distant lesion responses, and the limits of current evidence Estimated reading time: 20 minutes Abstract
Tag: cancer research
ATR and WEE1 Inhibitors After PARP Resistance: Emerging DNA Damage Response Strategies Across Solid Tumors
ATR and WEE1 Inhibitors After PARP Resistance: Emerging DNA Damage Response Strategies Across Solid Tumors Review Abstract Background Resistance to poly(ADP-ribose) polymerase (PARP) inhibition has intensified interest in other components of the DNA damage response and replication-stress network. Early clinical studies have evaluated ataxia telangiectasia
